Fluconazole 150 mg

DRUG6 trials

Sponsors

ProFem GmbH, University of Manitoba, Benha University, University of Oklahoma, Urooj Fatima

Conditions

Candidiasis, VulvovaginalCardiovascularDermatophytosisFungal RetinitisHealthyRecurrent Vulvovaginal CandidiasisTinea Corporis

Early Phase 1

Vulvovaginal Candidiasis in Canadian Females

RecruitingNCT04930107

University of ManitobaCandidiasis, Vulvovaginal

Start: 2021-12-07End: 2026-04-30Target: 105Updated: 2024-02-15

Phase 2

A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)

ProFem GmbHRecurrent Vulvovaginal Candidiasis

Start: 2019-10-01End: 2022-12-30Target: 432Updated: 2022-09-22

Phase 4

Endothelial Derived Hyperpolarization Factor and Vascular Control

RecruitingNCT05176379

University of OklahomaHealthy

Start: 2022-02-19End: 2025-05-31Target: 30Updated: 2024-07-23

Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis

RecruitingNCT07342153

Urooj FatimaDermatophytosis, Tinea Corporis

Start: 2025-11-01End: 2026-03-10Target: 126Updated: 2026-01-15

Unknown Phase

SD-OCT Guided Treatment of Fungal Chorioretinitis

Benha UniversityFungal Retinitis

Start: 2020-01-15End: 2022-01-31Target: 10Updated: 2021-12-15

The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting

RecruitingNCT07396857

Université de SherbrookeCardiovascular

Start: 2025-11-01End: 2026-12-15Target: 40Updated: 2026-02-09